At a glance
ClinicalIndex Comparison RecordN/ACompleted· 196 enrolled
Drug / intervention
Inspiratory muscle trainingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Resistance Inspiratory Muscle Training in the Management of Breathlessness in Patients With Thoracic Malignancies: A Randomized Controlled Trial
In Brief
A clinical study evaluating Inspiratory muscle training for Lung Neoplasm Malignant. Completed, enrolled 196 participants across 1 site.
Detailed Summary
A small-scale pilot randomized controlled trial conducted by the investigators demonstrated some preliminary evidence that inspiratory muscle training (IMT) could be a promising self-management method for alleviating breathlessness. Hence, the aim of this study is to assess the effectiveness of IMT in patients with thoracic malignancies on dyspnea.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Neoplasm Malignant
CountriesChina
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 2019
Enrollment StartNov 2019
Primary CompletionSep 2021
TodayJul 2026
First PostedFeb 7, 2019
Enrollment StartNov 23, 2019
Primary CompletionSep 15, 2021
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 7.4 years ago
Interventions
Inspiratory muscle trainingdevice
A pressure threshold device will be used to deliver IMT, which is commercially available by Phillips Respironics.